BLT 0.00% 2.6¢ benitec biopharma limited

these are the type of deals we want

  1. 2,381 Posts.
    lightbulb Created with Sketch. 9
    Regulus Therapeutics have a $US600million deal with GSK for up to 4 potential candidates using microRNA.

    http://finance.yahoo.com/news/Regulus-Therapeutics-and-prnews-99230071.html?x=0&.v=1

    BLT and ddRNAi need some industry support soon.

    The lack of any news on progress is not helping the share price, that's for sure.
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.